A Phase II Study to Evaluate the Efficacy and Safety of of DR10624 in Subjects With Severe Hypertriglyceridemia
Clinical trial NCT06555640 · COMPLETED
Trial details
- NCT number
- NCT06555640
- Sponsor
- Zhejiang Doer Biologics Co., Ltd.
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2024-08-01
- Primary completion
- 2025-06-30
- Enrollment
- 79
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.